Merck & Co.
Tracked across 15 events · 242 articles · First seen Feb 12, 2025 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: Merck & Co. is facing a federal securities class action lawsuit for allegedly making false and misleading statements regarding Gardasil sales in China, which led to a significant drop in its stock price.
Mar 15, 2025 · 6 articles
Business
Impact: Merck & Co. is facing a class action lawsuit for allegedly misleading investors about the sales forecasts of its Gardasil vaccine in China, leading to a significant stock price decline.
Feb 12, 2025 · 38 articles
Regulatory
Impact: Merck & Co. struck a deal to cut prices, committing to sell its diabetes drugs Januvia, Janumet, and Janumet XR at 70% off list prices directly to US consumers and pledging $70 billion in US R&D and manufacturing investments.
Dec 19, 2025 · 7 articles
Business
The biotech sector is experiencing a significant surge in mergers and acquisitions (M&A) in 2026, with deal values already reaching $84 billion in the first quarter, making it the strongest start since 2019. This accelerated…
Impact: Merck & Co. is a major drugmaker facing a patent cliff for its blockbuster cancer drug Pembrolizumab, which is a key driver for its acquisition strategy. It has been one of the top spenders on acquisitions this year.
May 01, 2026 · 6 articles
Tech
The United Kingdom — National Health Service is rolling out a new one-minute injection of the immunotherapy drug Pembrolizumab (Keytruda), manufactured by Merck & Co., for tens of thousands of cancer patients across the UK.…
Impact: Merck & Co. manufactures pembrolizumab (Keytruda), the drug being administered in the new one-minute injection. This innovation enhances the patient experience and improves productivity in cancer care.
May 03, 2026 · 8 articles
Accidents
A confirmed Ebola Virus Disease outbreak has been reported in Democratic Republic of the Congo — Ituri Province, Democratic Republic of the Congo, with 246 suspected cases and 65 deaths. Preliminary laboratory results from France…
Impact: Merck & Co. is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 6 articles
Domestic
Impact: Merck & Co., a hepatitis B vaccine maker, expressed deep concern over the ACIP's vote, and its shares closed down 1.2% on Friday.
Dec 05, 2025 · 7 articles
Business
Gossamer Bio is facing multiple securities class action lawsuits following the announcement on February 23, 2026, that its Phase 3 PROSERA study for seralutinib, a treatment for pulmonary arterial hypertension, failed to meet its primary…
Impact: Merck & Co. is mentioned as a reference for its successful Phase 3 STELLAR study, which Gossamer Bio management cited in comparison to their own trial.
Apr 01, 2026 · 103 articles
Business
A securities class action lawsuit has been filed against Gossamer Bio and an executive, representing investors who purchased Gossamer Bio securities between June 16, 2025, and February 20, 2026. The lawsuit stems from Gossamer Bio's…
Impact: Merck & Co. is mentioned as having a highly successful Phase 3 STELLAR study for treating PAH, which Gossamer Bio management cited in the past.
Apr 28, 2026 · 6 articles
Regulatory
Tracy Beth Høeg, the acting head of the United States — Food and Drug Administration's drug center, is expected to leave the agency shortly after Commissioner Marty Makary resigned. This departure is part of a…
Impact: Merck & Co. is mentioned in the context of Tracy Beth Høeg initiating safety questions over its approved protective RSV treatments for infants.
May 15, 2026 · 6 articles
Regulatory
Impact: Merck & Co. is mentioned as a company that has previously recalled drugs due to nitrosamine contamination, providing context to the current event.
Oct 29, 2025 · 8 articles
NEWSDESK
Track Merck & Co. live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard